Sientra Inc

-0.29 (-4.96%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)306.47M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$18.24 Million
Adjusted EPS-$0.21
See more estimates
10-Day MA$5.69
50-Day MA$5.92
200-Day MA$6.74
See more pivots

Sientra Inc Stock, NASDAQ:SIEN

420 South Fairview Avenue, Suite 200, Santa Barbara, California 93117
United States of America
Phone: +1.805.562.3500
Number of Employees: 255


Sientra, Inc. operates as a medical aesthetics company, which engages in developing and commercializing plastic surgery implantable devices. It operates through two reportable segments: Breast Products and miraDry. The Breast Products segment focuses on sales of its breast implants, tissue expanders and scar management products under the brands Sientra, AlloX2, Dermaspan, Softspan and BIOCORNEUM. The miraDry segment focuses on sales of the miraDry System, consisting of a console and a handheld device which uses consumable single-use bioTips. The company was founded by Hani M. Zeini on August 29, 2003 and is headquartered in Santa Barbara, CA.